Abiopharma

New Form 8-K - C4 Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001628280-25-038576 Size: 3 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits